Strategic plan for developing a universal influenza vaccine unveiled
NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine...
List view / Grid view
NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine...
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
NEWARK, Del. – W.L. Gore & Associates, Inc. (“Gore”), a global materials science company, will introduce its new GORE™ ImproJect™ Plunger at Pharmapack 2018, Europe's dedicated pharmaceutical packaging and drug delivery event. Gore will be in Booth A12 at the exhibition, to be held February 7 and 8, 2018, at…
Scientists have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug...
New injectable delivery system can slowly release drug carriers for months...
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate...
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera...
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...